Clinical Relatedness and Stability of vigiVec Semantic Vector Representations of Adverse Events and Drugs in Pharmacovigilance

被引:0
作者
Erlanson, Nils [1 ]
China, Joana Felix [1 ]
Taavola, Henric [1 ]
Noren, G. Niklas [1 ]
机构
[1] Uppsala Monitoring Ctr, Uppsala, Sweden
关键词
DATABASE; SAFETY;
D O I
10.1007/s40264-024-01509-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
IntroductionIndividual case reports are essential to identify and assess previously unknown adverse effects of medicines. On these reports, information on adverse events (AEs) and drugs are encoded in hierarchical terminologies. Encoding differences may hinder the retrieval and analysis of clinically related reports relevant to a topic of interest. Recent studies have explored the use of data-driven semantic vector representations to support analysis of pharmacovigilance data.ObjectiveThis study aims to evaluate the stability and clinical relatedness of vigiVec, a semantic vector representation for codes of AEs and drugs.MethodsvigiVec is a published adaptation to pharmacovigilance of the publicly available Word2Vec model, applied to structured data instead of free text. It provides vector representations for MedDRA (R) Preferred Terms and WHODrug Global active ingredients, learned from reporting patterns in VigiBase, the WHO global database of adverse event reports for medicines and vaccines. For this study, a 20-dimensional Skip-gram architecture with window size 250 was used. Our evaluation focused on nearest neighbors identified by the cosine similarity of vigiVec vector representations. Clinical relatedness was measured through term intruder detection, whereby a medical doctor was tasked to identify a randomly selected term-the intruder-included among the four nearest neighbors to a specific AE or drug. Stability was measured as the average overlap in the ten nearest neighbors for each AE or drug, in repeated fittings of vigiVec.ResultsAmong the ten nearest neighbors, 1.8 AEs on average belonged to the same MedDRA High Level Term (HLT; e.g., coagulopathies), and 1.3 drugs belonged to the same Anatomical Therapeutic Chemical level 3 (ATC-3; e.g., opioids). In the intruder detection task, when neighbors and intruders were both chosen from the same HLT, the intruder detection rate was 46%. When selected from different HLTs, it was 79%. By random chance, we should expect 20% (1 in 5). Corresponding rates for drugs were 42% in same ATC-3 and 65% in different ATC-3. The stability of nearest neighbors was 80% for AEs and 64% for drugs.ConclusionNearest neighbors identified with vigiVec are stable and show high level of clinical relatedness. They are often from different parts of the existing hierarchies and complement these.
引用
收藏
页码:401 / 413
页数:13
相关论文
共 27 条
  • [1] Bengio Y., 2009, ADV NEURAL INFORM PR, P288, DOI DOI 10.5555/2984093.2984126
  • [2] Accounting for multiplicities in assessing drug safety: A three-level hierarchical mixture model
    Berry, SM
    Berry, DA
    [J]. BIOMETRICS, 2004, 60 (02) : 418 - 426
  • [3] Are Word Embedding Methods Stable and Should We Care About It
    Borah, Angana
    Barman, Manash Pratim
    Awekar, Amit
    [J]. PROCEEDINGS OF THE 32ND ACM CONFERENCE ON HYPERTEXT AND SOCIAL MEDIA (HT '21), 2021, : 45 - 55
  • [4] Chiu B., 2016, P 15 WORKSH BIOM NAT, P166, DOI [DOI 10.18653/V1/W16-2922, 10.18653/v1/w16-2922]
  • [5] Ding X, 2021, AMIA ANN S P, V2020, P383
  • [6] ehek R., 2010, P LREC 2010 WORKSH N, P50, DOI DOI 10.13140/2.1.2393.1847
  • [7] Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
    Fusaroli, Michele
    Polizzi, Stefano
    Menestrina, Luca
    Giunchi, Valentina
    Pellegrini, Luca
    Raschi, Emanuel
    Weintraub, Daniel
    Recanatini, Maurizio
    Castellani, Gastone
    De Ponti, Fabrizio
    Poluzzi, Elisabetta
    [J]. DRUG SAFETY, 2024, : 1275 - 1292
  • [8] Gattepaille LM, 2019, IEEE INT CONF HEALT, P1, DOI [10.1109/ICHI.2019.8904551, DOI 10.1109/ichi.2019.8904551]
  • [9] Adverse event reporting and standardized medical terminologies: Strengths and limitations
    Goldman, SA
    [J]. DRUG INFORMATION JOURNAL, 2002, 36 (02): : 439 - 444
  • [10] Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System
    Harpaz, R.
    Perez, H.
    Chase, H. S.
    Rabadan, R.
    Hripcsak, G.
    Friedman, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 243 - 250